Response Biomedical Corp. of Vancouver, BC at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Response Biomedical Corp.

1781 West 75th Avenue, V6P 6P2 Vancouver, BC

Hall map

MEDICA 2019 hall map (Hall 1): stand F18

Fairground map

MEDICA 2019 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Our products

Product category: Immuno assay testing



  • Sepsis is a global health crisis with more than 30 million cases annually worldwide
  • Early detection and treatment of sepsis has been proven to improve patient outcomes and reduce healthcare costs
  • One-third of ICU patients with sepsis die before leaving the hospital
  • Sepsis is one of the most expensive conditions to treat, with costs exceeding $20 billion USD annually in the US alone


  • Procalcitonin(PCT) is a sensitive biomarker elevated in the blood of patients suffering from sepsis. Physicians use PCT to distinguish bacterial sepsis from other causes of similar symptoms
  • RAMP Procalcitonin provides quantitative results in ~15 minutes directly from a small blood sample.
  • When speed, precision and accuracy are critical, the RAMP® Procalcitonin test provides clinicians the results they need for making informed patient management decisions.

More Less

Product category: Immuno assay testing


Better results. Faster decisions.


All women of childbearing age require the accurate determination of their pregnancy status prior to medical intervention. Standard rapid qualitative urine tests fall short of this requirement in 3 critical ways:

  • Collecting samples from incapacitated patients in urgent situations is difficult
  • The results are subjective and can be biased
  • Monitoring of pregnancy status is not possible with a qualitative test

  • The RAMP Total β-hCG test gives medical professionals the ability to make treatment decisions based on pregnancy status immediately after patient arrival by testing routinely collected EDTA whole blood.
  • Clear results drive efficient decision making allowing better patient triage
  • Testing is possible for all patients regardless of their condition

More Less

Product category: Immuno assay testing


The gold standard biomarker for heart failure (HF)


  • Heart disease is the leading cause of death for both men and women around the globe.
  • 1 in 5 patients diagnosed with heart failure die within the first year.
  • Heart failure often presents with non-specific symptoms and is frequently confused with pneumonia or COPD
  • Heart attacks and Coronary Heart Disease are two of the most expensive conditions to treat.


  • Provides rapid, accurate diagnoses and assessment of congestive heart failure.
  • More stable then BNP
  • Better accuracy in mild heart failure
  • Standardize testing to Roche Elecsys

More Less

About us

Company details

What we do
The RAMP platform is a global leader in diagnostic testing solutions for use in cardiovascular, infectious disease, sepsis, women’s health, arbovirus and biodefense. We understand the stresses associated with rapid, accurate diagnosis when every minute counts, and are committed to collaborating with the teams that are dedicated to saving lives. We do this by providing lab-quality results within minutes that medical teams can trust, while reducing total cost of care.

Who we are
Response Biomedical has a global distribution network and is focused on enabling our strong network of partners to be leaders in their markets by providing exceptional levels of service and support. Response Biomedical fosters a values-based culture, committed to making diversity and inclusion our way of doing business. We believe the people we work with including our partners, medical teams and employees, are the cornerstone of our success. The Company has a world-class R&D and manufacturing facility located in Vancouver, Canada which is ISO 13485:2016 and ISO 9001:2015 certified.

Our Passion
Raising the bar in acute care diagnostics is our purpose and we work tirelessly to ensure patients receive diagnostic results with speed, precision and accuracy so their medical teams can confidently make informed patient management decisions accurately and quickly.

More Less